A BILL 
To require the Commissioner of Food and Drugs and the 
Director of the Centers for Disease Control and Preven-
tion to report to Congress all serious adverse events 
that are reported to such agencies in connection with 
administration of a COVID–19 vaccine, and for other 
purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Vaccine Transparency 
4
Act of 2021’’. 
5
23:37 Apr 14, 2021
H1473
2 
•HR 1473 IH
SEC. 2. REPORTS TO CONGRESS ON SERIOUS ADVERSE 
1
EVENTS IN CONNECTION WITH COVID–19 
2
VACCINES. 
3
(a) IN GENERAL.—Not later than 60 days after the 
4
date of enactment of this Act, and every 60 days there-
5
after, the Commissioner of Food and Drugs and the Direc-
6
tor of the Centers for Disease Control and Prevention, act-
7
ing jointly, shall submit a report to the Congress on all 
8
serious adverse events that are reported— 
9
(1) to either agency pursuant to the Vaccine 
10
Adverse Event Reporting System or otherwise dur-
11
ing the period covered by the report; and 
12
(2) in connection with a COVID–19 vaccine. 
13
(b) INITIAL REPORT.—The reporting period of the 
14
initial report under subsection (a) shall begin on the date 
15
when the Commissioner of Food and Drugs first author-
16
ized emergency use of a COVID–19 vaccine under section 
17
564 of the Federal Food, Drug, and Cosmetic Act (21 
18
U.S.C. 360bbb–3). 
19
Æ 
23:37 Apr 14, 2021
H1473
